Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nonpeptide NK1/NK2 antagonist identified by Merck & Co.

Nov. 1, 1996

NK1/NK2 antagonist research at Hoechst Marion Roussel

Nov. 1, 1996

Dual H1/NK1 antagonists as potential antiallergics

Nov. 1, 1996

Merck NK1 antagonist shows antiemetic activity in ferrets

Nov. 1, 1996

Third-generation ultrasound contrast agent from Sonus

Nov. 1, 1996

Prolonged treatment with Salagen Tablets not associated with tachyphylaxis

Nov. 1, 1996

Spotlight on NK1 antagonists

Nov. 1, 1996

Lanepitant in clinical trials for pain

Nov. 1, 1996

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.